CD40LG and Sepsis: Pieces of evidence support the use of IgM-enriched immunoglobulinsin a subgroup of patients with sepsis, showing improvement in survival[69, 70, 71], and when used prophylactically in patients undergoing procedures withcardiopulmonary bypass [72].